Variant report
Variant | esv275242 |
---|---|
Chromosome Location | chr7:48592013-48605608 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138069399 | chr7:48592035-48592036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149532675 | chr7:48592055-48592056 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527972299 | chr7:48592082-48592083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547703434 | chr7:48592097-48592098 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567846781 | chr7:48592119-48592120 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187247981 | chr7:48592150-48592151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563525438 | chr7:48592167-48592168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565157548 | chr7:48592189-48592190 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11453824 | chr7:48592190-48592191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs397800820 | chr7:48592201-48592202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548630450 | chr7:48592233-48592234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575474247 | chr7:48592245-48592246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537411945 | chr7:48592305-48592306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4551288 | chr7:48592306-48592307 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs75383235 | chr7:48592345-48592346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376739591 | chr7:48592349-48592350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6980042 | chr7:48592350-48592351 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs116566899 | chr7:48592352-48592353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573839082 | chr7:48592385-48592386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543147333 | chr7:48592430-48592431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192171613 | chr7:48592438-48592439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374510699 | chr7:48592453-48592454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183821617 | chr7:48592457-48592458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189891065 | chr7:48592464-48592465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111626621 | chr7:48592517-48592518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs58217465 | chr7:48592556-48592557 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs548061496 | chr7:48592622-48592623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561334128 | chr7:48592700-48592701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115190181 | chr7:48592707-48592708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs67316911 | chr7:48592709-48592710 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs568642969 | chr7:48592824-48592825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568439642 | chr7:48592825-48592826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550931533 | chr7:48592892-48592893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537523308 | chr7:48592953-48592954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551134887 | chr7:48592991-48592992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1918608 | chr7:48593039-48593040 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs116050961 | chr7:48593048-48593049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114867531 | chr7:48593108-48593109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192789536 | chr7:48593163-48593164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536418431 | chr7:48593194-48593195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs78854838 | chr7:48593253-48593254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35025866 | chr7:48593264-48593265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77703923 | chr7:48593270-48593271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576639858 | chr7:48593298-48593299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1609213 | chr7:48593300-48593301 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs558725073 | chr7:48593330-48593331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566642777 | chr7:48593335-48593336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535097984 | chr7:48593354-48593355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1609212 | chr7:48593357-48593358 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs541366686 | chr7:48593453-48593454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Biliary cancer | 19435499 | CNVD |
Wilms tumour | 21544195 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 22495311 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Gastric cancer | 24379144 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Ovarian cancer | 18182111 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Barrett''s esophagus | 18559552 | CNVD |
head and neck squamous cell carcinoma | 16943533 | CNVD |
Anaplastic thyroid cancer | 17079354 | CNVD |
Basal-like breast cancer | 17875215 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Colorectal cancer | 18794099 | CNVD |
Gastrointestinal stromal cancer | 17643098 | CNVD |
Lung cancer | 18381415 | CNVD |
Metastatic colorectal cancer | 17664472 | CNVD |
Non-small cell lung cancer | 19255323 | CNVD |
Non-small cell lung cancer | 17673923 | CNVD |
Non-small cell lung cancer | 17975165 | CNVD |
Non-small cell lung cancer | 19622585 | CNVD |
Ovarian cancer | 16607561 | CNVD |
Squamous cell cancer | 19670535 | CNVD |
head and neck squamous cell carcinoma | 16818711 | CNVD |
small cell lung cancer | 18829487 | CNVD |
Breast cancer | 17661082 | CNVD |
Adenocarcinoma | 19260752 | CNVD |
Esophageal cancer | 16575012 | CNVD |
Lung adenocarcinoma | 19138956 | CNVD |
Lung adenocarcinoma | 18379350 | CNVD |
Lung adenocarcinoma | 18258923 | CNVD |
Lung cancer | 19138956 | CNVD |
Lung cancer | 18379350 | CNVD |
Lung cancer | 18258923 | CNVD |
Non-small cell lung cancer | 18304967 | CNVD |
Non-small cell lung cancer | 19451690 | CNVD |
Non-small cell lung cancer | 19260752 | CNVD |
Non-small cell lung cancer | 17079354 | CNVD |
Non-small cell lung cancer | 18559607 | CNVD |
Rectal cancer | 19506820 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
head and neck squamous cell carcinoma | 18813952 | CNVD |
Non-small cell lung cancer | 17504988 | CNVD |
Non-small cell lung cancer | 16943533 | CNVD |
Non-small cell lung cancer | 18509184 | CNVD |
head and neck squamous cell carcinoma | 17538160 | CNVD |
Colorectal cancer | 19712476 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Lung cancer | 19671679 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:48589200-48602800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr7:48591400-48592200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr7:48594200-48599400 | Weak transcription | Primary hematopoietic stem cells | blood |
4 | chr7:48598400-48599000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr7:48599400-48600400 | Strong transcription | Primary hematopoietic stem cells | blood |
6 | chr7:48600400-48634200 | Weak transcription | Primary hematopoietic stem cells | blood |
7 | chr7:48602600-48603800 | Enhancers | HMEC | breast |
8 | chr7:48602800-48603000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr7:48602800-48603800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr7:48602800-48603800 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr7:48603000-48603400 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
12 | chr7:48603000-48603600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr7:48603000-48603600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
14 | chr7:48603000-48603600 | Enhancers | NHEK | skin |
15 | chr7:48603000-48603800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
16 | chr7:48603000-48603800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr7:48603400-48603600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr7:48603600-48603800 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
19 | chr7:48603800-48605000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
20 | chr7:48605000-48606600 | Strong transcription | Primary neutrophils fromperipheralblood | blood |
21 | chr7:48605400-48606200 | Enhancers | Fetal Heart | heart |